Question of the Week

This section is designed to address common issues, questions, and dilemmas experienced in clinical practice. Please think about the question and discuss with your colleagues, residents, and interns. Then visit us again to see commentary from the Contributing Editors and to compare your thoughts with theirs.

If you have a question you would like us to post, please email us at info@bugsvsdrugs.com.

1. What is the New Delhi (NDM-1) carbapenemase and will it impact your institution?
2. Is there any evidence that antimicrobial stewardship programs actually reduce bacterial resistance?
3. What's new in the management of Clostridium difficile infections?
4. Is MRSA increasingly responsible for community-acquired pneumonia?
5. Do you know what the modified Hodge test is?
6. Are hospitals compliant with CLSI guideline recommendations when generating antibiograms?